Patent · US Active

Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection

US8652457B2 · kind B2 · utility

9Cited by

1References

12Claims

0Family size

Assignee

Wisconsin Alumni Research Foundation · US

Inventors

Jordan Marshall Sand · Madison, US
Mark E. Cook · Madison, US

Key dates

Filing date	Jul 13, 2012
Grant date	Feb 18, 2014
Priority date	—
Expiry date	Jul 13, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be administered alone or as an animal feed additive to treat gastrointestinal protozoan infection in animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.